Browse hierarchy: [Anesthesiology (AN)](/submissions/AN) → [Subpart C — Monitoring Devices](/submissions/AN/subpart-c%E2%80%94monitoring-devices) → [21 CFR 868.2250](/submissions/AN/subpart-c%E2%80%94monitoring-devices/868.2250) → QVT — Monitor For Opioid Induced Impairment Of Oxygenation

# QVT · Monitor For Opioid Induced Impairment Of Oxygenation

_Anesthesiology · 21 CFR 868.2250 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/AN/subpart-c%E2%80%94monitoring-devices/QVT

## Overview

- **Product Code:** QVT
- **Device Name:** Monitor For Opioid Induced Impairment Of Oxygenation
- **Regulation:** [21 CFR 868.2250](/submissions/AN/subpart-c%E2%80%94monitoring-devices/868.2250)
- **Device Class:** 2
- **Review Panel:** [Anesthesiology](/submissions/AN)

## Identification

A monitor for opioid induced impairment of oxygenation is a device that uses sensor hardware and software algorithms to detect desaturations of arterial oxygen saturation resulting from opioid overdose. The Masimo SafetyNet Opioid System is intended for the non-invasive continuous monitoring of individuals 15 years and older for the identification of when they may be experiencing a substance induced impairment of oxygenation (e.g., opioid induced respiratory depression (OIRD) caused by oral or injectable opioids) in hospital and home environments.

## Classification Rationale

Class II (special controls). The device is granted under De Novo classification (21 CFR 868.2250) as the probable benefits outweigh the probable risks, and the risks can be mitigated by the use of general controls and the identified special controls.

## Special Controls

In combination with the general controls of the FD&C Act, the monitor for opioid induced impairment of oxygenation is subject to the following special controls:

## Recent Cleared Devices (1 of 1)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [DEN200011](https://fda.innolitics.com/submissions/AN/subpart-c%E2%80%94monitoring-devices/QVT/DEN200011.md) | Masimo SafetyNet | Masimo Corporation | Mar 31, 2023 | DENG |

## Top Applicants

- Masimo Corporation — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/AN/subpart-c%E2%80%94monitoring-devices/QVT](https://fda.innolitics.com/submissions/AN/subpart-c%E2%80%94monitoring-devices/QVT)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com